Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Can Specialty Healthcare Practices Find Operational Efficiency Post-COVID?

Recently, the American Medical Association published research regarding physicians’ Medicare spending during the first few months of the pandemic. In the study, “Changes in Medicare Physician Spending During the COVID-19 Pandemic,” the AMA discovered that specialty physicians in Dermatology, Ophthalmology, Otolaryngology, Gastroenterology, and Pathology reduced their spending from 23 to 29 percent. How has…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Recently, the American Medical Association published research regarding physicians’ Medicare spending during the first few months of the pandemic. In the study, “Changes in Medicare Physician Spending During the COVID-19 Pandemic,” the AMA discovered that specialty physicians in Dermatology, Ophthalmology, Otolaryngology, Gastroenterology, and Pathology reduced their spending from 23 to 29 percent. How has this reduction in expenditure impacted these doctors a year later?

To figure it out, Voice of B2B Daniel Litwin joined Terrence D. Sims, the President of Strategic Growth and Marketing of Raintree Systems, to discuss specialty healthcare. Raintree is a “digital healthcare solutions company working to centralize and customize specialized clinical practices through EMR/EHR software solutions.”

“The spending was largely attributed to the disruption during the closure period,” Sims said, as he expects Medicare spending to go back up, but not to previous levels due to expanded virtual health services.

But, it allowed healthcare providers a chance to examine how they deliver services to patients. Some solutions that arose were virtual care, telehealth, and remote patient monitoring. Though the technology was there, doctors relied on their old methodology, but the pandemic forced them to adapt.

“We now incorporate more technology than we probably ever have,” Sims said. With more spending going toward telehealth services, Medicare spending will stay on the lower end.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

UpDoc has received FDA clearance for its LLM-driven diabetes management app, while Aidoc has been granted breakthrough device status for its AI-drafted radiology reports. This marks a significant milestone as clinical AI applications continue to gain regulatory approval and recognition. The advancements showcase the potential of AI in improving healthcare management and diagnostic processes.

  • 01UpDoc's diabetes management app receives FDA clearance.
  • 02Aidoc achieves breakthrough device status for AI radiology reports.
  • 03Regulatory milestones highlight AI's growing role in healthcare.

Jul 13, 2026

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

The chief data and AI officer at Cedars-Sinai discusses the evolving role of AI in healthcare. While the first wave of AI focused on enhancing productivity, the second wave is expected to transform job roles and the workforce structure. This shift indicates a deeper integration of AI technology in healthcare operations.

  • 01First wave of AI increased productivity in healthcare.
  • 02Second wave aims to restructure job roles.
  • 03AI will deeply integrate into healthcare operations.

Jul 13, 2026

Automation adoption gap widens in US manufacturing as medtech presses ahead

Automation adoption gap widens in US manufacturing as medtech presses ahead

Automation in US manufacturing lags, with 80% of factories lacking automation tools. In contrast, medtech manufacturers are advancing with technologies like micro-molding and ultrasonic welding. This disparity highlights a growing gap in technology adoption across different sectors.

  • 0180% of US factories have no automation.
  • 02Medtech manufacturers are investing in automation technologies.
  • 03There's an increasing divide in technology adoption across industries.

Jul 12, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512